Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

SIOG 2014 /
Age and chemotherapy choices: risk factors versus benefit?

23rd - 25th Oct 2014

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 10.11.14
Views: 2072

Dr Christos Markopoulos - Athens University Medical School, Athens, Greece

"Age proved to be the most important factor to undergo - or not undergo - chemotherapy," Dr Markopoulos tells ecancertv at SIOG 2014. He discusses the results of a multidisciplinary survey of 900 physicians in 52 countries, examining the interaction between age and breast cancer screening, diagnosis and outcome. 

The survey seems to indicate that physicians are more reluctant to prescribe chemotherapy to geriatric patients, and that elderly patients require more proof of benefit.


Breast · Elderly · Complications · Cytotoxics · SIOG 2014

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation